Compound Detail
CHEMBL113366
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL113366 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BHVYVHFYFNCJHA-AWEZNQCLSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
339.4
MW (Da)
0.60
ALogP
4
HBA
3
HBD
98.7
PSA (Ų)
0.60
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.08
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Homo sapiens CHEMBL372 | IC50 | 7.08 | 7.08 | 83.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Homo sapiens | IC50 | = | 83.0 | nM | 7.08 | Concentration required to inhibit the rate of platelet aggregation by 50% was de... | 7650686 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7650686 | 10.1021/jm00017a017 | Homo sapiens | 1 |
Data from ChEMBL 36 via Core Engine